PURPOSE: To investigate pharmacokinetics of reversibly stabilized DNA nanoparticles (rSDN) using a single-step lysis RT-PCR. METHODS: rSDN were prepared by coating bioreducible polycation/DNA polyplexes with multivalent N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers. Targeted polyplexes were formulated by linking cyclic RGD ligand (c(RGDyK)) to the HPMA surface layer of rSDN. The pharmacokinetic parameters in tumor-bearing mice were analyzed by PKAnalyst. RESULTS: The pharmacokinetics of naked plasmid DNA, simple DNA polyplexes, rSDN, and RGD-targeted rSDN exhibited two-compartment model characteristics with area under the blood concentration-time curve (AUC) increasing from 1,102 ng x ml(-1) x min(-1) for DNA to 3,501 ng x ml(-1) x min(-1) for rSDN. Non-compartment model analysis revealed increase in mean retention time (MRT) from 4.5 min for naked DNA to 22.9 min for rSDN. CONCLUSIONS: RT-PCR is a sensitive and convenient method suitable for analyzing pharmacokinetics and biodistribution of DNA polyplexes. Surface stabilization of DNA polyplexes can significantly extend their MRT and AUC compared to naked DNA. DNA degradation in rSDN in blood circulation, due to a combined effect of disulfide reduction and competitive reactions with charged molecules in the blood, contributes to DNA elimination.
PURPOSE: To investigate pharmacokinetics of reversibly stabilized DNA nanoparticles (rSDN) using a single-step lysis RT-PCR. METHODS:rSDN were prepared by coating bioreducible polycation/DNA polyplexes with multivalent N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers. Targeted polyplexes were formulated by linking cyclic RGD ligand (c(RGDyK)) to the HPMA surface layer of rSDN. The pharmacokinetic parameters in tumor-bearing mice were analyzed by PKAnalyst. RESULTS: The pharmacokinetics of naked plasmid DNA, simple DNA polyplexes, rSDN, and RGD-targeted rSDN exhibited two-compartment model characteristics with area under the blood concentration-time curve (AUC) increasing from 1,102 ng x ml(-1) x min(-1) for DNA to 3,501 ng x ml(-1) x min(-1) for rSDN. Non-compartment model analysis revealed increase in mean retention time (MRT) from 4.5 min for naked DNA to 22.9 min for rSDN. CONCLUSIONS: RT-PCR is a sensitive and convenient method suitable for analyzing pharmacokinetics and biodistribution of DNA polyplexes. Surface stabilization of DNA polyplexes can significantly extend their MRT and AUC compared to naked DNA. DNA degradation in rSDN in blood circulation, due to a combined effect of disulfide reduction and competitive reactions with charged molecules in the blood, contributes to DNA elimination.
Authors: P M Mullen; C P Lollo; Q C Phan; A Amini; M G Banaszczyk; J M Fabrycki; D Wu; A T Carlo; P Pezzoli; C C Coffin; D J Carlo Journal: Biochim Biophys Acta Date: 2000-09-01
Authors: Qing-Hui Zhou; Douglas L Miller; Robert C Carlisle; Leonard W Seymour; David Oupicky Journal: J Control Release Date: 2005-09-02 Impact factor: 9.776
Authors: G Bellomo; M Vairetti; L Stivala; F Mirabelli; P Richelmi; S Orrenius Journal: Proc Natl Acad Sci U S A Date: 1992-05-15 Impact factor: 11.205
Authors: Liu H Wei; Tove Olafsen; Caius Radu; Isabel J Hildebrandt; Mark R McCoy; Michael E Phelps; Claude Meares; Anna M Wu; Johannes Czernin; Wolfgang A Weber Journal: J Nucl Med Date: 2008-10-16 Impact factor: 10.057
Authors: Zinnia P Parra-Guillén; Gloria González-Aseguinolaza; Pedro Berraondo; Iñaki F Trocóniz Journal: Pharm Res Date: 2010-04-13 Impact factor: 4.200
Authors: Rajesh R Patil; Jianhua Yu; Sangeeta R Banerjee; Yong Ren; Derek Leong; Xuan Jiang; Martin Pomper; Benjamin Tsui; Dara L Kraitchman; Hai-Quan Mao Journal: Mol Ther Date: 2011-07-12 Impact factor: 11.454
Authors: C A Fernandez; N J Baumhover; J T Duskey; S Khargharia; K Kizzire; M D Ericson; K G Rice Journal: Gene Ther Date: 2010-08-19 Impact factor: 5.250
Authors: Kandarp M Dave; Linjiang Han; Meredith A Jackson; Lindsay Kadlecik; Craig L Duvall; Devika S Manickam Journal: Pharm Res Date: 2020-08-28 Impact factor: 4.580